Drug Approval | June 08, 2023
European Commission authorises GSK’s Arexvy for older adults
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
_256_384.jpg)
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
The workshop strived to sensitize states and various stakeholder departments regarding their role in the implementation of National Patient Safety Implementation Framework, as well as augment capacity building of health care professionals
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
Subscribe To Our Newsletter & Stay Updated
